The Annexure

News to 9 October 2026 ·

What the ground filed.

A desk of BSE disclosures — every listed company, sliced the way you need it.

Data as of 9 October 2026

Change in Management

1. Approval of re-appointment of Mrs. Abha Agrawal (DIN: 01589479) as a Non Executive Non-Independent Director of the Company post attaining the age of 75 years , and who retires by rotation, ....

The filing

1. Approval of re-appointment of Mrs. Abha Agrawal (DIN: 01589479) as a Non Executive Non-Independent Director of the Company post attaining the age of 75 years , and who retires by rotation, ....

Company
Ishita Drugs & Industries Ltd · BSE 524400
Filed
2 October 2026, 17:55 IST
BSE category
Company Update / Change in Management
Tag
Change in Management · selected
Source
Open the filing on BSE →

Why it led

  • First Change in Management from this company — not seen in the 93 trading days on record
  • Micro cap

Selected by the ranker from 15 filings that day. Each line above is a component of that score, not a comment on the filing.

How often this tag appears

2,694 of 90,553 filings in the published window carry Change in Management · 2.98%

Around it

Also filed by Ishita Drugs & Industries Ltd on 2 October 2026

Most recent filings from Ishita Drugs & Industries Ltd

The company

Ishita Drugs & Industries Ltd

BSE 524400 · NSE ISHITADR · ISIN INE806D01016 · Group X · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

Full figures, price and filing history for Ishita Drugs & Industries Ltd →